Records containing: Hypochondroplasia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Vosoritide in Infants and Young Children With Hypochondroplasia, Aged 0 to < 36 Months
-
CLINICAL_TRIALS study record update · 2026-02-20Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia Using Syde®
-
CLINICAL_TRIALS study record update · 2026-02-06Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Hypochondroplasia: ACCEL OLE
-
CLINICAL_TRIALS study record update · 2026-01-20A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vosoritide in Children With Hypochondroplasia
-
CLINICAL_TRIALS study record update · 2025-12-15A Phase 2/3, Multicenter, Open-Label Phase Followed by a Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Infigratinib in Children With Hypochondroplasia: ACCEL 2/3
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-10Prospective Clinical Assessment Study in Children With Hypochondroplasia: ACCEL
-
CLINICAL_TRIALS study record update · 2025-07-18A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia
-
CLINICAL_TRIALS study record update · 2025-04-03A Multicenter Multinational Observational Study of Children With Hypochondroplasia
-
CLINICAL_TRIALS study record update · 2022-04-28Local Registry for Data Collection of Patients With Achondroplasia / Hypochondroplasia for Epidemiological, Care and Research Studies
-
CLINICAL_TRIALS study record update · 2019-02-15Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated Over a Period of 3 Years or 5 Years if Applicable, in Comparison With a Historic Cohort of Non-treated Children With Hypochondroplasia
-
CLINICAL_TRIALS study record update · 2015-04-14C-Type Natriuretic Peptide and Achondroplasia